Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer

Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer

Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.

Inclusion Criteria:

• Patients with metastatic solid tumor
• Age> 18 years
• Signed consent

Exclusion Criteria:

• Patients with diseases associated with vascular lesions known.
• Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the Code of Public Health.
• Mental pathology that can interfere with the proper conduct of the study.
• Refusal of consent.